Sales decline 42.55% to Rs 9.49 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 15.06 crore in the quarter ended March 2019 as against net loss of Rs 34.17 crore during the previous quarter ended March 2018. Sales declined 42.55% to Rs 9.49 crore in the quarter ended March 2019 as against Rs 16.52 crore during the previous quarter ended March 2018.For the full year,net loss reported to Rs 19.73 crore in the year ended March 2019 as against net loss of Rs 16.45 crore during the previous year ended March 2018. Sales declined 8.08% to Rs 43.36 crore in the year ended March 2019 as against Rs 47.17 crore during the previous year ended March 2018.
ParticularsQuarter EndedYear EndedMar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.Sales9.4916.52 -43 43.3647.17 -8 OPM %-135.72-198.79 --30.74-74.35 - PBDT-12.80-32.93 61 -14.81-40.66 64 PBT-13.57-33.70 60 -18.23-44.31 59 NP-15.06-34.17 56 -19.73-16.45 -20
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
